Diamonds and Dogs
11/30/22
Horizon Therapeutics (HZNP) jumps on takeover rumors. The biotech known for their thyroid eye disease therapy and chronic gout drug is jumping 25% on rumors of takeover talks with Amgen, Johnson & Johnson and Sanofi. The talks are preliminary. Earnings beat as revenues rose 52.8% to $580.88 million.
Crowdstrike (CRWD) strikes out. The cybersecurity firm is taking a hit, down 19% following earnings and lower guidance. Earnings beat as revenues rose 52.8% to $580.88 million, but net new annual recurring revenue missed expectations. Guidance was not particularly good as increased economic headwinds are causing some customers to delay purchases.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.